Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe.

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Stomach NeoplasmLymph Node MetastasisRADIONUCLIDE IMAGING
Interventions
DIAGNOSTIC_TEST

99mTc-3PRGD2 Spect-CT scan

Before the operation,SPECT-CT imaging of lymph nodes was performed by integrin αvβ3-specific 99mTc-3PRGD2 probe. The locations of 99mTc-3PRGD2 SPECT-CT were determined by preoperative CT scan. During the operation, D2 lymph node dissection of gastric cancer was performed under the guidance of fluorescent laparoscopy。

All Listed Sponsors
lead

Peking University Cancer Hospital & Institute

OTHER

NCT06435741 - Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe. | Biotech Hunter | Biotech Hunter